Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2 is a research paper published in PLoS Pathogens (2020). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R56AI145407
National Institutes of Health
Grant: R01AI110173
National Institutes of Health
Grant: R01AI120698
National Cancer Institute
Grant: R01CA166741
National Cancer Institute
Grant: R01CA172503
National Institutes of Health
Grant: 5R01CA172503-02
Regulation of Death Ligand-Induced Killing
National Institutes of Health
Grant: 5R01CA166741-04
Anticancer drug-induced BH3-only protein.Bak interactions
National Institutes of Health
Grant: 1R56AI145407-01A1
BCL2 family proteins promote HIV-1 persistence
National Institutes of Health
Grant: 5R01AI110173-02
Prime shock and kill for HIV erradication
National Institutes of Health
Grant: 5R01AI120698-03
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals